Article

Silencing of Hepatic AATF Ameliorates Metabolic Dysfunction Associated Steatohepatitis by…

medRxiv · 2024 · N. Srinivas, A.; Suresh, D.; Moorthy, M.; Ramaswamy, G.; Santhekadur, P. K.; Suvarna, D.; Kumar, D. P.

Key facts

Title Silencing of Hepatic AATF Ameliorates Metabolic Dysfunction Associated Steatohepatitis by Promoting Fatty Acid β-Oxidation in Experimental models
First author N. Srinivas, A.; Suresh, D.; Moorthy, M.; Ramaswamy, G.; Santhekadur, P. K.; Suvarna, D.; Kumar, D. P.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.05.25.595878
Devices mentioned K071580
Product codes mentioned CIT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature